Nocion Therapeutics
PrivateLast Round
Series B
Extension
Jan 7, 2026
Est. Valuation
$125M
Total Funding Raised
$135M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nocion Therapeutics operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a Series B Extension round in January 2026.
Nocion Therapeutics is a biopharmaceutical company developing a new class of small molecule charged sodium channel blockers, called nocions, to treat conditions such as chronic cough, pain, and itch.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nocion Therapeutics Comparables
Compare Nocion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeRRe Therapeutics | 82% | |
| Axalbion | 80% | |
| GSK plc | 78% |
For institutional investors. Book with your work email.
Nocion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 7, 2026 | ||||
| Early Stage VC | Dec 15, 2025 | ||||
| Series B | Mar 4, 2024 | ||||
| VC Round | Aug 18, 2021 | ||||
| Series A | Jan 25, 2021 | ||||
Series A | Apr 17, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nocion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series B, Series B Extension, Series A |
| Mass General Brigham Innovation | Series B Extension, Series B, Series A |
| Mass General Brigham Ventures | Series B Extension |
| Osage University Partners | Series B, Series B Extension |
| BioInnovation Capital | Series B, Series A, Series B Extension |
| Monograph Capital | Series B, Series B Extension |
| Canaan Partners | Series B, Seed, Series A, Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 54% MoM.
- Jan 7, 2026
$23M raised in Series B Extension round.
For institutional investors. Book with your work email.
Nocion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nocion Therapeutics's valuation, stock price, and market status.
Is Nocion Therapeutics a public or private company?
Nocion Therapeutics is a private company.
What is the current stock price of Nocion Therapeutics?
Nocion Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nocion Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nocion Therapeutics worth (valuation)?
Nocion Therapeutics's valuation is estimated at $125.0M based on funding round data.
Can I buy Nocion Therapeutics stock?
Nocion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nocion Therapeutics's last funding round?
Nocion Therapeutics's most recent funding round was Series B Extension on January 7, 2026.
Who are the main investors in Nocion Therapeutics?
Key investors in Nocion Therapeutics include F-Prime Capital, Monograph Capital, Arkin Bio Capital, F-Prime Capital.
Will Nocion Therapeutics IPO soon?
No public IPO plans have been announced for Nocion Therapeutics.
How can I track Nocion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nocion Therapeutics's shares on secondary markets.